Robert Francomano

Chief Commercial Officer at SynOx Therapeutics

Speaker

Robert Francomano is Chief Commercial Officer at SynOx Therapeutics, where he is building a fully integrated commercial and medical affairs infrastructure to support the company’s inaugural launch of a therapy for patients with rare and aggressive giant cell tumors. He brings over 25 years of experience in the pharmaceutical and biotechnology sectors, including serving as CCO of Stemline Therapeutics, where he transformed the organization into a global commercial enterprise and led a top-ranked rare oncology launch. Earlier in his career, he held senior oncology commercial roles at Pfizer, GlaxoSmithKline, and AstraZeneca, establishing the foundation of his expertise in the biotech industry.